Enhanced CRISPR/Cas9-mediated precise genome editing by improved design and delivery of gRNA, Cas9 nuclease, and donor DNA

被引:185
作者
Liang, Xiquan [1 ]
Potter, Jason [1 ]
Kumar, Shantanu [1 ]
Ravinder, Namritha [1 ]
Chesnut, Jonathan D. [1 ]
机构
[1] Thermo Fisher Sci, 5781 Allen Way, Carlsbad, CA 92008 USA
关键词
CRISPR; Cas9; gRNA; Genome editing; Knock-in; Homologous recombination; STEM-CELLS; GENERATION; OLIGODEOXYNUCLEOTIDES; MUTATIONS;
D O I
10.1016/j.jbiotec.2016.11.011
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
While CRISPR-based gene knock out in mammalian cells has proven to be very efficient, precise insertion of genetic elements via the cellular homology directed repair (HDR) pathway remains a rate-limiting step to seamless genome editing. Under the conditions described here, we achieved up to 56% targeted integration efficiency with up to a six-nucleotide insertion in HEK293 cells. In induced pluripotent stem cells (iPSCs), we achieved precise genome editing rates of up to 45% by co-delivering the Cas9 RNP and donor DNA. In addition, the use of a short double stranded DNA oligonucleotide with 3' overhangs allowed integration of a longer FLAG epitope tag along with a restriction site at rates of up to 50%. We propose a model that favors the design of donor DNAs with the change as close to the cleavage site as possible. For small changes such as SNPs or short insertions, asymmetric single stranded donor molecules with 30 base homology arms 3' to the insertion/repair cassette and greater than 40 bases of homology on the 5' end seems to be favored. For larger insertions such as an epitope tag, a dsDNA donor with protruding 3' homology arms of 30 bases is favored. In both cases, protecting the ends of the donor DNA with phosphorothioate modifications improves the editing efficiency. (C) 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
引用
收藏
页码:136 / 146
页数:11
相关论文
共 25 条
[1]  
BROWN DA, 1994, J BIOL CHEM, V269, P26801
[2]   Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease [J].
Cho, Seung Woo ;
Kim, Sojung ;
Kim, Jong Min ;
Kim, Jin-Soo .
NATURE BIOTECHNOLOGY, 2013, 31 (03) :230-232
[3]   Phosphorothioate oligodeoxynucleotides: What is their origin and what is unique about them? [J].
Eckstein, F .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 2000, 10 (02) :117-121
[4]   An iCRISPR Platform for Rapid, Multiplexable, and Inducible Genome Editing in Human Pluripotent Stem Cells [J].
Gonzalez, Federico ;
Zhu, Zengrong ;
Shi, Zhong-Dong ;
Lelli, Katherine ;
Verma, Nipun ;
Li, Qing V. ;
Huangfu, Danwei .
CELL STEM CELL, 2014, 15 (02) :215-226
[5]   Targeted gene correction by small single-stranded oligonucleotides in mammalian cells [J].
Igoucheva, O ;
Alexeev, V ;
Yoon, K .
GENE THERAPY, 2001, 8 (05) :391-399
[6]   Rapid generation of mouse models with defined point mutations by the CRISPR/Cas9 system [J].
Inui, Masafumi ;
Miyado, Mami ;
Igarashi, Maki ;
Tamano, Moe ;
Kubo, Atsushi ;
Yamashita, Satoshi ;
Asahara, Hiroshi ;
Fukami, Maki ;
Takada, Shuji .
SCIENTIFIC REPORTS, 2014, 4
[7]   RNA-guided editing of bacterial genomes using CRISPR-Cas systems [J].
Jiang, Wenyan ;
Bikard, David ;
Cox, David ;
Zhang, Feng ;
Marraffini, Luciano A. .
NATURE BIOTECHNOLOGY, 2013, 31 (03) :233-239
[8]   The Mechanism of Gene Targeting in Human Somatic Cells [J].
Kan, Yinan ;
Ruis, Brian ;
Lin, Sherry ;
Hendrickson, Eric A. .
PLOS GENETICS, 2014, 10 (04)
[9]   A Co-CRISPR Strategy for Efficient Genome Editing in Caenorhabditis elegans [J].
Kim, Heesun ;
Ishidate, Takao ;
Ghanta, Krishna S. ;
Seth, Meetu ;
Conte, Darryl, Jr. ;
Shirayama, Masaki ;
Mello, Craig C. .
GENETICS, 2014, 197 (04) :1069-U37
[10]   Directed evolution of the TALE N-terminal domain for recognition of all 5' bases [J].
Lamb, Brian M. ;
Mercer, Andrew C. ;
Barbas, Carlos F., III .
NUCLEIC ACIDS RESEARCH, 2013, 41 (21) :9779-9785